SYNCROMUNE
Syncromune is a clinical-stage biopharmaceutical company developing novel intratumoral immunotherapies for solid tumors. The company is developing Syncrovax, a proprietary platform technology that uses a combination approach to synchronize the timing and location of tumor antigen release with the functional activation of immune cells. Syncromune's mission is to optimize intratumoral, immuno-oncology drug development, and to bring life-changing therapies to cancer patients in need. It was founded in 2020 and is based in Fort Lauderdale, Florida.
SYNCROMUNE
Industry:
Biotechnology Life Science Pharmaceutical Therapeutics
Founded:
2020-01-01
Address:
Fort Lauderdale, Florida, United States
Country:
United States
Website Url:
http://www.syncromune.com
Total Employee:
1+
Status:
Active
Contact:
954-429-6088
Email Addresses:
[email protected]
